Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations

被引：1
|
作者：
Feng, J. [1 ]
Hueniken, K. [2 ]
Fan, Z. [1 ]
Faour, E. [1 ]
Corke, L. [1 ]
Leighl, N. [1 ]
Liu, G. [1 ]
Bradbury, P. [1 ]
Sacher, A.
Eng, L.
Stockley, T. [3 ]
Tsao, M-S. [1 ]
Shepherd, F. A. [1 ]
机构：
[1] UHN Univ Hlth Network, Med Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] UHN Univ Hlth Network, Biostast, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] UHN Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2386
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1353P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer
    Cho, Sukki
    Kim, Min Jung
    Choi, Yi Young
    Yoo, Seung Soo
    Lee, Won Kee
    Lee, Eun Jin
    Jang, Eun Jeong
    Bae, Eun Young
    Jin, Guang
    Jeon, Hyo-Sung
    Lee, Shin Yup
    Cha, Sung-Ick
    Park, Tae In
    Kim, Chang Ho
    Park, Jae Yong
    LUNG CANCER, 2011, 73 (01) : 25 - 31
  • [32] Correlation of TP53/KMT2C co-mutation and Tumor Microenvironment in Lung Cancer
    Zhang, X.
    Zhang, L.
    Ren, B.
    Tang, X.
    Liu, H.
    Wang, Y.
    Zhang, Z.
    Zhao, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1143 - S1144
  • [33] Frequency of TP53 mutations in relation to Arg72Pro genotypes in non-small cell lung cancer
    Lind, Helge
    Ekstrom, Per Olaf
    Ryberg, David
    Skaug, Vidar
    Andreassen, Tove
    Stangeland, Lodve
    Haugen, Aage
    Zienolddiny, Shanbeh
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (10) : 2077 - 2081
  • [34] VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy
    Schwaederle, Maria
    Lazar, Vladimir
    Validire, Pierre
    Hansson, Johan
    Lacroix, Ludovic
    Soria, Jean-Charles
    Pawitan, Yudi
    Kurzrock, Razelle
    CANCER RESEARCH, 2015, 75 (07) : 1187 - 1190
  • [35] TP53 Mutations in Nonsmall Cell Lung Cancer
    Mogi, Akira
    Kuwano, Hiroyuki
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [36] TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
    Liu, Surui
    Yu, Jin
    Zhang, Hui
    Liu, Jie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Non-small-cell lung cancer patients harboring TP53/KRAS co-mutation could benefit from a PD-L1 inhibitor
    Zhang, Chenyue
    Wang, Kai
    Lin, Jiamao
    Wang, Haiyong
    FUTURE ONCOLOGY, 2022, 18 (27) : 3031 - 3041
  • [38] Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
    Wang, Feng
    Zhao, Ning
    Gao, Ge
    Deng, Hong-Bin
    Wang, Zhi-Hui
    Deng, Li-Li
    Yang, Yu
    Lu, Changlian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2851 - 2859
  • [39] Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
    Feng Wang
    Ning Zhao
    Ge Gao
    Hong-Bin Deng
    Zhi-Hui Wang
    Li-Li Deng
    Yu Yang
    Changlian Lu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2851 - 2859
  • [40] The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer
    Zhang, YuXuan
    Shen, Yuhong
    Wu, Jiayuan
    Zhang, Jun
    Cao, Chenxi
    Mo, Juanfen
    Bao, Yi
    ONCOTARGETS AND THERAPY, 2024, 17 : 755 - 763
12345